VistaGen Therapeutics VTGN
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.66 | 51 | -32.23 | -19 | -25.89 | 65 |
| 2025Q3 | 3.55 | 66 | -31.55 | -19 | -25.91 | 81 |
| 2025Q2 | 2.00 | 57 | -23.74 | -15 | -19.70 | 69 |
| 2025Q1 | 2.50 | 70 | -18.00 | -14 | -15.44 | 84 |
| 2024Q4 | 2.95 | 81 | -16.19 | -14 | -14.46 | 92 |
| 2024Q3 | 3.01 | 93 | -13.11 | -13 | -12.00 | 102 |
| 2024Q2 | 3.48 | 105 | -9.80 | -11 | -9.05 | 114 |
| 2024Q1 | 5.28 | 114 | -8.02 | -10 | -7.48 | 124 |
| 2023Q4 | 5.14 | 123 | -7.99 | -6 | -7.33 | 131 |
| 2023Q3 | 5.24 | 36 | -31.01 | -7 | -23.02 | 42 |
| 2023Q2 | 1.87 | 7 | -72.94 | -7 | -38.22 | 15 |
| 2023Q1 | 3.74 | 12 | -74.66 | -12 | -48.14 | 21 |
| 2022Q4 | 3.09 | 21 | -38.83 | -10 | -27.73 | 30 |
| 2022Q3 | 4.56 | 30 | -46.22 | -17 | -35.17 | 41 |
| 2022Q2 | 26.40 | 46 | -35.71 | -20 | -29.66 | 59 |
| 2022Q1 | 37.20 | 65 | -23.07 | -17 | -20.21 | 75 |
| 2021Q4 | 58.50 | 80 | -13.12 | -11 | -11.03 | 91 |
| 2021Q3 | 82.20 | 81 | -15.39 | -13 | -12.52 | 101 |
| 2021Q2 | 94.50 | 86 | -8.72 | -8 | -7.30 | 104 |
| 2021Q1 | 63.90 | 92 | -6.69 | -6 | -5.71 | 108 |